Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1992 1
1993 1
1994 2
1995 1
1996 1
1997 1
1998 4
1999 2
2001 1
2002 1
2005 1
2008 1
2009 3
2010 1
2011 3
2012 1
2013 3
2014 2
2015 3
2018 1
2019 1
2021 1
2022 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.
Mech A, Rasmussen K, Jantunen P, Aicher L, Alessandrelli M, Bernauer U, Bleeker EAJ, Bouillard J, Di Prospero Fanghella P, Draisci R, Dusinska M, Encheva G, Flament G, Haase A, Handzhiyski Y, Herzberg F, Huwyler J, Jacobsen NR, Jeliazkov V, Jeliazkova N, Nymark P, Grafström R, Oomen AG, Polci ML, Riebeling C, Sandström J, Shivachev B, Stateva S, Tanasescu S, Tsekovska R, Wallin H, Wilks MF, Zellmer S, Apostolova MD. Mech A, et al. Among authors: aicher l. Nanotoxicology. 2019 Feb;13(1):119-141. doi: 10.1080/17435390.2018.1513092. Epub 2018 Sep 5. Nanotoxicology. 2019. PMID: 30182766 Review.
Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma.
Andtbacka RHI, Wang Y, Pierce RH, Campbell JS, Yushak M, Milhem M, Ross M, Niland K, Arbeit RD, Parasuraman S, Bickley K, Yeung CC, Aicher LD, Smythe KS, Gan L. Andtbacka RHI, et al. Among authors: aicher ld. Cancer Res Commun. 2022 Aug 31;2(8):904-913. doi: 10.1158/2767-9764.CRC-22-0090. eCollection 2022 Aug. Cancer Res Commun. 2022. PMID: 36923305 Free PMC article. Clinical Trial.
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma.
Wagner MJ, Zhang Y, Cranmer LD, Loggers ET, Black G, McDonnell S, Maxwell S, Johnson R, Moore R, Hermida de Viveiros P, Aicher L, Smythe KS, He Q, Jones RL, Pollack SM. Wagner MJ, et al. Among authors: aicher l. Clin Cancer Res. 2022 Jun 1;28(11):2306-2312. doi: 10.1158/1078-0432.CCR-22-0240. Clin Cancer Res. 2022. PMID: 35349638 Free PMC article. Clinical Trial.
Aberrant beta-catenin signaling in tuberous sclerosis.
Mak BC, Kenerson HL, Aicher LD, Barnes EA, Yeung RS. Mak BC, et al. Among authors: aicher ld. Am J Pathol. 2005 Jul;167(1):107-16. doi: 10.1016/s0002-9440(10)62958-6. Am J Pathol. 2005. PMID: 15972957 Free PMC article.
Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury.
Gralinski LE, Bankhead A 3rd, Jeng S, Menachery VD, Proll S, Belisle SE, Matzke M, Webb-Robertson BJ, Luna ML, Shukla AK, Ferris MT, Bolles M, Chang J, Aicher L, Waters KM, Smith RD, Metz TO, Law GL, Katze MG, McWeeney S, Baric RS. Gralinski LE, et al. Among authors: aicher l. mBio. 2013 Aug 6;4(4):e00271-13. doi: 10.1128/mBio.00271-13. mBio. 2013. PMID: 23919993 Free PMC article.
Modeling host genetic regulation of influenza pathogenesis in the collaborative cross.
Ferris MT, Aylor DL, Bottomly D, Whitmore AC, Aicher LD, Bell TA, Bradel-Tretheway B, Bryan JT, Buus RJ, Gralinski LE, Haagmans BL, McMillan L, Miller DR, Rosenzweig E, Valdar W, Wang J, Churchill GA, Threadgill DW, McWeeney SK, Katze MG, Pardo-Manuel de Villena F, Baric RS, Heise MT. Ferris MT, et al. Among authors: aicher ld. PLoS Pathog. 2013 Feb;9(2):e1003196. doi: 10.1371/journal.ppat.1003196. Epub 2013 Feb 28. PLoS Pathog. 2013. PMID: 23468633 Free PMC article.
42 results